![Dave Gardner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dave Gardner
Corporate Officer/Principal at
INCYTE CORPORATION
Net worth: 912 161 $ as of 31/05/2026
Profile
Dave Gardner is Chief Strategy Officer & Executive Vice President at Incyte Corp.
since 2025.
Former roles include Director at Xilio Therapeutics, Inc., Vice President at BlackRock Finance, Inc. from 2006 to 2015, and Analyst at Rock Springs Capital Management LP from 2015 to 2025.
Education includes an MBA from Columbia Business School conferred in 2015 and an undergraduate degree from McIntire School of Commerce.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 22/09/2025 | 9,429 ( 0% ) | 912 161 $ | 31/05/2026 |
Dave Gardner active positions
| Companies | Position | Start |
|---|---|---|
| INCYTE CORPORATION | Corporate Officer/Principal | 22/09/2025 |
Former positions of Dave Gardner
| Companies | Position | End |
|---|---|---|
Rock Springs Capital Management LP
 Rock Springs Capital Management LP Investment ManagersFinance Rock Springs’ funds aim to generate capital appreciation through investments in a combination of public and private securities of companies in healthcare and healthcare-related industries. The funds focus mostly on public equities, utilizing a long-term, research-intensive approach to investing. | Analyst-Equity | 01/09/2025 |
BlackRock Finance, Inc.
 BlackRock Finance, Inc. Investment ManagersFinance Provides asset and investment advisory & risk management solutions | Corporate Officer/Principal | 01/05/2015 |
| XILIO THERAPEUTICS, INC. | Director/Board Member | - |
Training of Dave Gardner
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
86
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
BlackRock Finance, Inc.
BlackRock Finance, Inc. Investment ManagersFinance Provides asset and investment advisory & risk management solutions | Finance |
Rock Springs Capital Management LP
Rock Springs Capital Management LP Investment ManagersFinance Rock Springs’ funds aim to generate capital appreciation through investments in a combination of public and private securities of companies in healthcare and healthcare-related industries. The funds focus mostly on public equities, utilizing a long-term, research-intensive approach to investing. | Finance |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McIntire School of Commerce
 McIntire School of Commerce Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
- Stock Market
- Insiders
- Dave Gardner
